Zenas BioPharma (ZBIO) earnings
In the quarter ended June 2026, Zenas BioPharma had revenue of $1M, and diluted EPS of -1.77.
On August 13, 2026 it reported EPS of -1.77 against an estimate of -0.89 (missed).
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Last | Thu Aug 13, 2026 | — | -0.89 | -1.77 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from Zenas BioPharma's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $1M | — | -1.77 | — | -10765.9% | 2026-08-13 |
| Mar 31, 2026 | — | — | -1.46 | — | — | 2026-05-13 |
| Dec 31, 2025 | $0 | — | — | — | — | 2026-03-16 |
| Sep 30, 2025 | $0 | — | -1.22 | — | — | 2025-11-12 |
| Jun 30, 2025 | $0 | — | -1.25 | — | — | 2025-08-12 |
| Mar 31, 2025 | $10M | — | -0.80 | — | -373.3% | 2025-05-15 |
| Dec 31, 2024 | $5M | — | — | — | -1112.5% | 2025-03-11 |
| Sep 30, 2024 | $0 | — | -5.02 | -356.1% | — | 2024-11-12 |
| Jun 30, 2024 | $0 | — | -24.23 | — | — | 2024-11-12 |
| Mar 31, 2024 | — | — | -17.89 | — | — | 2024-11-12 |
| Dec 31, 2023 | $0 | — | — | — | — | 2025-03-11 |
| Sep 30, 2023 | $50M | — | 1.96 | — | 71.2% | 2024-11-12 |
Questions
How did Zenas BioPharma do last quarter?
In the quarter ended June 2026, Zenas BioPharma had revenue of $1M, and diluted EPS of -1.77.
From Zenas BioPharma's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.